Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

Hasty Decisions, Runaway Projects
Despite the best intentions of ISO and EMA, the pharma industry is still largely failing to exploit its data in a strategic, joined-up way - and this could now restrict companies’ ability to capitalize on AI. read more
Safely Scaling Highly Potent API manufacturing
Ever more drug developers are searching for CDMOs with contamination-limiting capabilities. But how can they know which have these high-potency credentials? read more
Five Steps to Smooth Agentic AI Adoption
In agentic AI-enabled labs, AI goes from individual, one-off applications to comprehensive workflow orchestration. read more
Horizon Lines: A Quarterly Review of NDAs – January-March, 2026
The NDAs approved during the first quarter of 2026 have been divided into the dosage forms Injection, Tablets, Capsules, Oral solution, Gas, and other. read more

View More Editorial Articles »

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

View More Videos »

View More Whitepapers & Application Notes »

Axplora Manufacturing Sites Earn EcoVadis Ratings Across European Network
Thursday, July 09, 2026
Axplora reported updated EcoVadis sustainability ratings for four of its European manufacturing sites, with one site achieving platinum status and ... read more
Porton Advanced's UC-MSCs Cell Bank for Exosome Manufacturing Receives FDA Drug Master File (DMF) Acceptance
Thursday, July 09, 2026
Porton Advanced announced that its Umbilical Cord-Derived Mesenchymal Stem Cell (UC-MSCs) Cell Bank for exosome manufacturing has been accepted for ... read more
WuXi Biologics’ MFG8 Facility Gains FDA Pre License Inspection Approval For Autoimmune Therapy
Thursday, July 09, 2026
WuXi Biologics has received FDA pre license inspection (PLI) approval for its MFG8 drug substance manufacturing facility in Hebei, clearing the way ... read more
Evonik Invests $100M to Upgrade Drug Substance Manufacturing Site in Lafayette, IN
Wednesday, July 08, 2026
Evonik announced it is making a significant investment to strengthen manufacturing capabilities at its Tippecanoe Labs site in Lafayette, Indiana. read more
Mikart Appoints Chief Executive Officer
Tuesday, July 07, 2026
Mikart announced that Darrin T. Schellin has joined the company as Chief Executive Officer. read more

View More News »

Axplora Manufacturing Sites Earn EcoVadis Ratings Across European Network
Thursday, July 09, 2026
Porton Advanced's UC-MSCs Cell Bank for Exosome Manufacturing Receives FDA Drug Master File (DMF) Acceptance
Thursday, July 09, 2026
WuXi Biologics’ MFG8 Facility Gains FDA Pre License Inspection Approval For Autoimmune Therapy
Thursday, July 09, 2026

April/May/June 2026

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

AAPS Summer Scientific Forum 2026
Monday, July 13, 2026
3rd Cell & Gene Therapy Pricing & Reimbursement Summit
Tuesday, July 14, 2026
MedTech Validation: Smarter V&V, Design Controls, and Digital Device Files
Wednesday, July 22, 2026

View More Events »

2026 Company Focus & Industry Reference Guide
View Issue

Subscriptions

Get started here for yourcomplimentary print ordigital subscription

Get started here for your complimentary magazine subscription